Brainsway EBITDA 2018-2025 | BWAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Brainsway ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Brainsway ebitda from 2018 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$226.7B
Boston Scientific (BSX)	$152.7B
Stryker (SYK)	$145.9B
EssilorLuxottica (ESLOY)	$145.2B
Medtronic (MDT)	$119B
Lonza Group Ag (LZAGY)	$48.3B
Haleon (HLN)	$43.4B
ResMed (RMD)	$41.9B
Agilent Technologies (A)	$33.6B
GE HealthCare Technologies (GEHC)	$33.4B
Terumo (TRUMY)	$27.9B
Koninklijke Philips (PHG)	$26.4B
Insulet (PODD)	$22.7B
Zimmer Biomet Holdings (ZBH)	$20.3B
Smith & Nephew SNATS (SNN)	$15.9B
Baxter (BAX)	$12.1B
Sunny Optical Technology (SNPTF)	$10.8B
Demant (WILYY)	$8.1B
Bio-Rad Laboratories (BIO)	$7.7B
Lantheus Holdings (LNTH)	$3.8B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.5B
Prestige Consumer Healthcare (PBH)	$3.2B
Perrigo (PRGO)	$3.2B
ICU Medical (ICUI)	$3B
Haemonetics (HAE)	$2.6B
LeMaitre Vascular (LMAT)	$2.2B
Curaleaf Holdings (CURLF)	$1.9B
AtriCure (ATRC)	$1.8B
QuidelOrtho (QDEL)	$1.8B